Read about Sildenafil citrate, another potent vasodilator for use among PAH patients.| Pulmonary Hypertension News
Patients and clinicians endorsed Opsynvi as a single-tablet combination therapy for PAH in interviews conducted during a clinical trial.| Pulmonary Hypertension News
Low-dose metformin delivered to the pulmonary arteries using lipid-based nanocapsules, safely eased signs of PAH in rats.| Pulmonary Hypertension News
Read about adcirca, a phosphodiesterase 5 inhibitor, another mechanism of slowing down disease progression in pulmonary hypertension patients| Pulmonary Hypertension News
Read about his other PH news from around the web.| Pulmonary Hypertension News
Underweight infants with pulmonary hypertension (PH) are at increased risk of developing retinopathy of prematurity (ROP), a leading cause of childhood blindness, according to a study. However, the prevalence of severe ROP was 18% lower in PH infants who received treatment with inhaled nitric oxide (iNO). “While iNO is not a treatment for ROP, these […] The post Underweight infants with PH at high risk for eye disease: Study appeared first on Pulmonary Hypertension News.| Pulmonary Hypertension News – The Web's Daily Resource for PH News
The European Patent Office has given Tenax Therapeutics notice that it plans to grant a patent covering the use of levosimendan and its active metabolites to treat pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF), the company said. TNX-103, an oral formulation currently in Phase 3 testing for PH-HFpEF, is among the versions […] The post Tenax sees European patent for levosimendan to treat PH-HFpEF appeared first on Pulmonary Hypertension News.| Pulmonary Hypertension News – The Web's Daily Resource for PH News
“Acceptance doesn’t mean resignation; it means understanding that something is what it is and that there’s got to be a way through it.” — Michael J. Fox For over 10 years, I’ve been navigating life with chronic pain, a silent battle I’ve fought while managing pulmonary hypertension (PH) and other health issues. The quote above […] The post Finding strength in acceptance when living with chronic pain appeared first on Pulmonary Hypertension News.| Pulmonary Hypertension News – The Web's Daily Resource for PH News
Allrock Bio has raised $50 million in financing to support the clinical development of pulmonary hypertension (PH) treatment ROC-101. The company said it will use the funds to launch a Phase 2a clinical trial to test ROC-101 in people with pulmonary arterial hypertension (PAH) or pulmonary hypertension associated with interstitial lung disease (PH-ILD). Allrock said the […] The post Allrock gets financing to start trial of PH treatment this year appeared first on Pulmonary Hypertension News.| Pulmonary Hypertension News – The Web's Daily Resource for PH News
Phaware, a global advocacy organization, is launching a special podcast series to raise awareness of pulmonary arterial hypertension (PAH) caused by the use of methamphetamine, a stimulant drug known for its psychoactive effects. Methamphetamine-induced PAH is now known simply as Meth-PAH. The six-episode series, part of the “I’m Aware That I’m Rare” podcast, premieres Sept. […] The post 6-part special podcast series aims to raise awareness of Meth-PAH appeared first on Pulmonary Hy...| Pulmonary Hypertension News – The Web's Daily Resource for PH News
Pulmonary endarterectomy (PEA), a surgery to remove blood clots in individuals with chronic thromboembolic pulmonary hypertension (CTEPH), may be more effective in improving pulmonary circulation and heart function than balloon pulmonary angioplasty (BPA), according to a recent study. After treatment, a higher proportion of patients in the BPA group remained with residual symptoms. BPA is […] The post PEA surgery may be more effective than BPA for CTEPH: Study appeared first on Pulmonary Hy...| Pulmonary Hypertension News – The Web's Daily Resource for PH News
Pulmonary hypertension (PH) can feel like a hand is squeezing my lungs, and my arteries are tentacles of fire. Sometimes I feel like a large iron block is sitting atop my heart, squashing it and causing heart failure. The pressure can get intense. This disabled heart of mine is an advanced case. I used to think […] The post Sticky bras are good for the heart appeared first on Pulmonary Hypertension News.| Pulmonary Hypertension News – The Web's Daily Resource for PH News
Whether you’re 5 or 15, back-to-school season can involve all sorts of overwhelming factors when living with pulmonary hypertension (PH) or another complex illness. Along with shopping for school supplies and planning an outfit for school pictures, PH warriors also have to worry about medication management, energy allowance, and overall health maintenance. These are a […] The post Some plans that helped me go back to school can still apply appeared first on Pulmonary Hypertension News.| Pulmonary Hypertension News – The Web's Daily Resource for PH News
Stanford University has been awarded a grant from the U.S. National Institutes of Health (NIH) to begin a Phase 2 clinical trial of pulmonary arterial hypertension (PAH) treatment tiprelestat, the treatment’s developer announced. Tiakis Biotech said tiprelestat was found to be safe in earlier clinical trials involving more than 100 participants. The new trial, ATHENA, […] The post Stanford awarded NIH grant for PAH treatment clinical trial appeared first on Pulmonary Hypertension News.| Pulmonary Hypertension News – The Web's Daily Resource for PH News
Corvista Health’s point-of-care device can detect cases of PH that other testing methods miss, according to a recent case series.| Pulmonary Hypertension News
While PH Awareness Month is a great opportunity to connect and educate, rare disease advocacy is columnist Jen Cueva's passion all year.| Pulmonary Hypertension News
Columnist Colleen Steele took a break from writing after her husband passed away in 2023, but she's ready to keep raising PH awareness.| Pulmonary Hypertension News
Esteban holds a Master of Science in Immunology from the Instituto Politécnico Nacional in Mexico, focused on inflammation and metabolism. With five years of experience as a Medical Science Liaison, he has worked directly with physicians across a wide range of specialties, covering topics...| Pulmonary Hypertension News
PH patients face barriers to timely care from symptom onset through treatment and follow-up, a study found.| Pulmonary Hypertension News
A 68-year-old man with severe PAH and multiple coexisting conditions experienced marked improvement after receiving combination therapy.| Pulmonary Hypertension News
Learn more about pulmonary hypoxic hypertension, which is caused by a shortage of oxygen in the body (hypoxia), and classified as a type of group 3 pulmonary hypertension by the World Health Organization (WHO).| Pulmonary Hypertension News
Exosomes released by mesenchymal stem cells may help reduce vascular remodeling and ease PH symptoms, a rat study showed.| Pulmonary Hypertension News
LungFit PH, Beyond Air's nitric oxide therapy device, has received the European CE mark approval for pulmonary hypertension in newborns.| Pulmonary Hypertension News
Steve Bryson is a science writer for Pulmonary Hypertension News with a PhD in biochemistry. He covers the latest news and information on a variety of pulmonary hypertension topics.| Pulmonary Hypertension News
Read about the different classes of the World Health Organization's (WHO) Pulmonary Hypertension Functional Classification.| Pulmonary Hypertension News
Three months of CS1 therapy boosted quality of life, while symptoms tied to heart failure and clinical worsening and mortality risk declined.| Pulmonary Hypertension News
The U.S. FDA has granted orphan drug designation to CS1, Cereno Scientific’s lead therapy candidate for treating pulmonary arterial hypertension (PAH).| Pulmonary Hypertension News
Cereno's expanded access program for investigational therapy CS1 covers 10 PAH patients, following a Phase 2a clinical trial.| Pulmonary Hypertension News
The investigational therapy CS1 led to beneficial changes in for people with pulmonary arterial hypertension in a Phase 2a clinical trial.| Pulmonary Hypertension News
The FDA has approved the use of Cereno Scientific’s CS1 in an extension of the ongoing Phase 2 trial testing the therapy in people with PAH.| Pulmonary Hypertension News
After positive trial results for TX45, Tectonic Therapeutic is planning a Phase 2 study to test its effects on blood flow in PH-ILD patients.| Pulmonary Hypertension News
A 5-year-old boy with a neuroblastoma developed PAH after receiving a high dose of chemotherapy to prepare for a stem cell transplant.| Pulmonary Hypertension News
Marisa Wexler is a senior science writer for Pulmonary Hypertension News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of pulmonary hypertension topics.| Pulmonary Hypertension News
No description.| Pulmonary Hypertension News
Corvista Health’s point-of-care device, used to predict pulmonary hypertension (PH), also appears to work well at identifying heart failure.| Pulmonary Hypertension News
The FDA granted breakthrough device designation to CorVista for its system diagnosing pulmonary hypertension and cardiovascular disorders.| Pulmonary Hypertension News
Margarida Maia is a science writer for Pulmonary Hypertension News with a PhD in biomedical sciences. She covers the latest news and information on a variety of pulmonary hypertension topics.| Pulmonary Hypertension News
The Aeson Total Artificial Heart helped three people with heart failure and pulmonary hypertension become eligible for a heart transplant.| Pulmonary Hypertension News
The immune protein STAT6 may be a driver of pulmonary hypertension in people with obstructive sleep apnea, a study in mice suggests.| Pulmonary Hypertension News
Researchers developed a tool for predicting the prognosis of people with chronic lung disease-related pulmonary hypertension.| Pulmonary Hypertension News
A larger diameter of the main pulmonary artery predicts poorer outcomes in pulmonary arterial hypertension (PAH) patients, a study found.| Pulmonary Hypertension News
NORD has launched a U.S. study called Living Rare to capture the lived experiences of rare disease patients and identify changing unmet needs.| Pulmonary Hypertension News
The FDA has approved Yutrepia, an inhaled treprostinil formulation, for the treatment of PAH and PH-ILD, two forms of pulmonary hypertension.| Pulmonary Hypertension News
Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).| Pulmonary Hypertension News
Read about the reasons for the development of pulmonary hypertension (PH).| Pulmonary Hypertension News
INOpulse is a portable device by Bellerophon Therapeutics that supplies pulses of nitric oxide, being tested to treat forms of pulmonary hypertension.| Pulmonary Hypertension News
In hypoxic pulmonary hypertension, exosomes derived from stem cells may be a therapy option for preventing abnormal muscle cell growth.| Pulmonary Hypertension News
Early treatment with iNO and pulmonary surfactant reduces the risk of developing BPD associated with PH in preterm infants, a study found.| Pulmonary Hypertension News
Sensydia has completed a development study of its Cardiac Performance System device to detect pulmonary hypertension and heart failure.| Pulmonary Hypertension News
Sensydia reports completing a 5th study supporting algorithms for its Cardiac Performance System to quickly detect pulmonary hypertension.| Pulmonary Hypertension News
Supporters will unite on May 5 to mark World Pulmonary Hypertension Day, with a focus this year on early diagnosis.| Pulmonary Hypertension News
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto...| Pulmonary Hypertension News
Looking for reliable information on Thromboembolic Pulmonary Hypertension? Find out everything you need to know here.| Pulmonary Hypertension News
Looking for information about pulmonary venous hypertension? PVH's causes, symptoms, diagnosis, and treatments are highlighted here.| Pulmonary Hypertension News
Read about the methods and difficulties to diagnose the lung disease pulmonary hypertension (PH).| Pulmonary Hypertension News
Mutations in certain genes can cause or increase the likelihood of someone developing PAH. This is known as familial or heritable PAH.| Pulmonary Hypertension News
No description.| Pulmonary Hypertension News
Increasing irisin, found at lower levels in people with PAH, may help slow disease progression by stopping vascular remodeling, per a study.| Pulmonary Hypertension News
A protein called BMPER found at low levels in models has emerged as a PAH treatment target as it may ease disease progression, per a study.| Pulmonary Hypertension News
Read about the various types of pulmonary hypertension, and their causes, as classified by the World Health Organization (WHO).| Pulmonary Hypertension News
Platelets tend to cluster in lung blood vessels in people with decompensated pulmonary hypertension, increasing their risk of bleeding, a study says.| Pulmonary Hypertension News
Adding more lines of treatment may reduce the risk of rehospitalization among adults with PAH who are taking only one medication, per a study.| Pulmonary Hypertension News
Many patients with heart dysfunction have pulmonary hypertension, more so if they have enlarged hearts or irregular heartbeats, per a study.| Pulmonary Hypertension News
Pulmonary arterial hypertension (PAH) is a rare type of pulmonary hypertension that can be the result of one of several causes, or by no apparent cause. Read more information about PAH here.| Pulmonary Hypertension News
Using a machine-learned algorithm, Corvista's system can accurately diagnose pulmonary hypertension in a noninvasive way, a study shows.| Pulmonary Hypertension News
Some of the common symptoms of pulmonary hypertension include shortness of breath, excessive fatigue, weakness, chest pain, and fainting.| Pulmonary Hypertension News
Category archive page for News.| Pulmonary Hypertension News
Lindsey Shapiro is a science writer for Pulmonary Hypertension News with a PhD in neuroscience. She covers the latest news and information on a variety of pulmonary hypertension topics.| Pulmonary Hypertension News
A combination treatment may improve survival in patients with both pulmonary hypertension and pulmonary fibrosis, a study found.| Pulmonary Hypertension News
Category archive page for Columns.| Pulmonary Hypertension News
A pivotal study testing Sensydia's noninvasive device, which may help diagnose pulmonary hypertension, enrolled its first participant.| Pulmonary Hypertension News
Cereno Scientific reported a successful meeting with the FDA on the design of a future clinical trial for its PAH therapy candidate CS1.| Pulmonary Hypertension News
Heart failure related to PAH is becoming more common, with patients living fewer years in full health, a trend that’s predicted to continue.| Pulmonary Hypertension News
Pulmonary hypertension (PH) is a chronic and progressive disease associated with high blood pressure in the blood vessels that supply the lungs, known as the pulmonary arteries. Read more about PH here.| Pulmonary Hypertension News